Verge Genomics
YC S15 · Active · We use human data and AI to develop better drugs faster.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW15 | |
| AI | Active | YCW20 | |
| AI | Active | YCW26 | |
| Other | Active | YCS21 | |
| AI | Active | YCS21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW22 | |
| AI | Acquired | YCS15 | |
| Other | Not stated | EF2019 | |
| AI | Active | YCS25 | |
| AI | Active | YCW26 |
Also from S15 in AI
All of S15About Verge Genomics
Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.
- YC batch
- S15 · Summer 2015
- Status, per YC
- Active
- Category
- AI
- Team size
- 50
- Location
- San Francisco, CA, USA
- Checked
- 35m ago
Verge Genomics: questions
Which YC batch was Verge Genomics in?
Verge Genomics was in Y Combinator's Summer 2015 batch (S15).
Is Verge Genomics still active?
Y Combinator lists Verge Genomics as active.
Where is Verge Genomics based?
Verge Genomics lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.